Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Molecular mechanisms of insulin resistance in chronic kidney disease.

Thomas SS, Zhang L, Mitch WE.

Kidney Int. 2015 Dec;88(6):1233-1239. doi: 10.1038/ki.2015.305. Epub 2015 Oct 7.

PMID:
26444029
2.

MiR-19a regulates PTEN expression to mediate glycogen synthesis in hepatocytes.

Dou L, Meng X, Sui X, Wang S, Shen T, Huang X, Guo J, Fang W, Man Y, Xi J, Li J.

Sci Rep. 2015 Jun 26;5:11602. doi: 10.1038/srep11602.

3.

SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function.

Ahmed CM, Larkin J 3rd, Johnson HM.

Front Immunol. 2015 Apr 21;6:183. doi: 10.3389/fimmu.2015.00183. eCollection 2015. Review.

4.

FOXO1 content is reduced in cystic fibrosis and increases with IGF-I treatment.

Smerieri A, Montanini L, Maiuri L, Bernasconi S, Street ME.

Int J Mol Sci. 2014 Oct 8;15(10):18000-22. doi: 10.3390/ijms151018000.

5.

The role of suppressors of cytokine signalling in human neoplasms.

Sasi W, Sharma AK, Mokbel K.

Mol Biol Int. 2014;2014:630797. doi: 10.1155/2014/630797. Epub 2014 Mar 16. Review.

6.

Inputs and outputs of insulin receptor.

Du Y, Wei T.

Protein Cell. 2014 Mar;5(3):203-13. doi: 10.1007/s13238-014-0030-7. Epub 2014 Mar 16. Review.

7.

Increases in insulin sensitivity among obese youth are associated with gene expression changes in whole blood.

Miranda DN, Coletta DK, Mandarino LJ, Shaibi GQ.

Obesity (Silver Spring). 2014 May;22(5):1337-44. doi: 10.1002/oby.20711. Epub 2014 Feb 18.

8.

Ketoacidosis at diagnosis of type 1 diabetes in children and adolescents: frequency and clinical characteristics.

Onyiriuka AN, Ifebi E.

J Diabetes Metab Disord. 2013 Dec 19;12(1):47. doi: 10.1186/2251-6581-12-47.

9.

SOCS proteins in development and disease.

Trengove MC, Ward AC.

Am J Clin Exp Immunol. 2013 Feb 27;2(1):1-29. Print 2013.

10.

Suppressor of cytokine signaling 6 (SOCS6) negatively regulates Flt3 signal transduction through direct binding to phosphorylated tyrosines 591 and 919 of Flt3.

Kazi JU, Sun J, Phung B, Zadjali F, Flores-Morales A, Rönnstrand L.

J Biol Chem. 2012 Oct 19;287(43):36509-17. doi: 10.1074/jbc.M112.376111. Epub 2012 Sep 5.

11.

Satellite cells derived from obese humans with type 2 diabetes and differentiated into myocytes in vitro exhibit abnormal response to IL-6.

Scheele C, Nielsen S, Kelly M, Broholm C, Nielsen AR, Taudorf S, Pedersen M, Fischer CP, Pedersen BK.

PLoS One. 2012;7(6):e39657. doi: 10.1371/journal.pone.0039657. Epub 2012 Jun 26.

12.

Suppressor of cytokine signalling-6 promotes neurite outgrowth via JAK2/STAT5-mediated signalling pathway, involving negative feedback inhibition.

Gupta S, Mishra K, Surolia A, Banerjee K.

PLoS One. 2011;6(11):e26674. doi: 10.1371/journal.pone.0026674. Epub 2011 Nov 17.

13.

Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.

Serrano-Marco L, Rodríguez-Calvo R, El Kochairi I, Palomer X, Michalik L, Wahli W, Vázquez-Carrera M.

Diabetes. 2011 Jul;60(7):1990-9. doi: 10.2337/db10-0704. Epub 2011 May 26.

14.

Insulin and GH signaling in human skeletal muscle in vivo following exogenous GH exposure: impact of an oral glucose load.

Krusenstjerna-Hafstrøm T, Madsen M, Vendelbo MH, Pedersen SB, Christiansen JS, Møller N, Jessen N, Jørgensen JO.

PLoS One. 2011 May 3;6(5):e19392. doi: 10.1371/journal.pone.0019392.

15.

Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention.

Badawi A, Klip A, Haddad P, Cole DE, Bailo BG, El-Sohemy A, Karmali M.

Diabetes Metab Syndr Obes. 2010 May 26;3:173-86.

16.

Pim3 negatively regulates glucose-stimulated insulin secretion.

Vlacich G, Nawijn MC, Webb GC, Steiner DF.

Islets. 2010 Sep-Oct;2(5):308-17. Epub 2010 Sep 1.

17.

The role of adipose tissue and adipokines in obesity-related inflammatory diseases.

Balistreri CR, Caruso C, Candore G.

Mediators Inflamm. 2010;2010:802078. doi: 10.1155/2010/802078. Epub 2010 Jul 1. Review.

18.

cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance.

Sabio G, Davis RJ.

Trends Biochem Sci. 2010 Sep;35(9):490-6. doi: 10.1016/j.tibs.2010.04.004. Epub 2010 May 7. Review.

19.

SOCS-6 negatively regulates T cell activation through targeting p56lck to proteasomal degradation.

Choi YB, Son M, Park M, Shin J, Yun Y.

J Biol Chem. 2010 Mar 5;285(10):7271-80. doi: 10.1074/jbc.M109.073726. Epub 2009 Dec 10.

20.

Roles of IL-6-gp130 Signaling in Vascular Inflammation.

Hou T, Tieu BC, Ray S, Recinos Iii A, Cui R, Tilton RG, Brasier AR.

Curr Cardiol Rev. 2008 Aug;4(3):179-92. doi: 10.2174/157340308785160570.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk